2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$5.38-$0.30 (-5.21%)
Price as of Oct 02, 2026 4:35 PM EDT- $221.2MMarket Cap
- -4.05%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$5.38-$0.30 (-5.21%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.68 | ||
Change | -$0.67 (-10.55%) | ||
Open | $6.32 | ||
High | $6.36 | ||
Low | $5.60 | ||
Previous Close | $6.35 | ||
Volume | 425,138 | ||
30-Day Average Volume | 331,511 | ||
1-Week Change | -8.68% | ||
1-Month Change | -19.66% | ||
1-Year Change | -4.05% | ||
3-Year Change | -64.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $298.9M | ||
Market Cap | $221.2M | ||
Enterprise Value | $121.9M | ||
Period: QTR TTM FY | |||
Revenue | $898,000.00 | ||
Net Income | -$42.8M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$42.7M | ||
EBITDA | -$41.9M | ||
Net Working Capital | $211.3M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 136 | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue